Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 2—Investigation of Bias in Extra-Fine Mass Fraction with AIM-HRT Impactor-Reference-Cited by-同舟云学术

Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 2—Investigation of Bias in Extra-Fine Mass Fraction with AIM-HRT Impactor

Published:2010-07-10 Issue:3 Volume:11 Page:1115-1118
ISSN:1530-9932
Container-title:AAPS PharmSciTech
language:en
Short-container-title:AAPS PharmSciTech

Author:

Mitchell Jolyon P.,Nagel Mark W.,Doyle Cathy C.,Ali Rubina S.,Avvakoumova Valentina I.,Christopher J. David,Quiroz Jorge,Strickland Helen,Tougas Terrence,Lyapustina Svetlana

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics

Link

http://link.springer.com/content/pdf/10.1208/s12249-010-9473-1.pdf

Reference16 articles.

1. Mitchell JP, Nagel MW, Doyle CC, Ali RS, Avvakoumova VI, Christopher JD, et al. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated Andersen cascade impactors (ACIs): Part 1. AAPS PharmSciTech. 2010;11:843–51. doi: http://dx.doi.org/10.1208/s12249-010-9452-6 .

2. Mitchell JP, Nagel MW, Avvakoumova V, MacKay H, Ali R. The abbreviated impactor measurement (AIM) concept: Part 1—Influence of particle bounce and re-entrainment—evaluation with a “dry” pressurized metered dose inhaler (pMDI)-based formulation. AAPS PharmSciTech. 2009;10(1):243–51. doi: 10.1208/s12249-009-9202-9 .

3. Christopher D, Curry P, Doub B, Furnkranz K, Lavery M, Lin K, et al. Considerations for the development and practice of cascade impaction testing including a mass balance failure investigation tree. J Aerosol Med. 2003;16:235–47.

4. United States Pharmacopeial Convention. US Pharmacopeia 32/National Formulary 27, Rockville, MD. Monograph for albuterol.

5. Dolovich M. Measurement of particle size characteristics of metered dose inhaler (MDI) aerosols. J Aerosol Med. 1991;4:251–63.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Particle Size Measurements from Orally Inhaled and Nasal Drug Products;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2021-12-01

2. Addressing the Need for Controls on Particle Bounce and Re-entrainment in the Cascade Impactor and for the Mitigation of Electrostatic Charge for Aerodynamic Particle Size Assessment of Orally Inhaled Products: an Assessment by the International Consortium on Regulation and Science (IPAC-RS);AAPS PharmSciTech;2020-08-21

3. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol;AAPS PharmSciTech;2017-06-06

4. Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI);AAPS PharmSciTech;2016-09-13

5. A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals;AAPS PharmSciTech;2016-04-11